As of 2025-07-15, the Relative Valuation of Kaleido Biosciences Inc (KLDO) is (11,782,312.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.29 USD, the upside of Kaleido Biosciences Inc based on Relative Valuation is -4062866320.6%.
The range of the Relative Valuation is (11,751,866.79) - (11,216,030.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 18.4x | 18.0x |
| Forward P/E multiples | 19.3x - 22.4x | 20.6x |
| Fair Price | (11,751,866.79) - (11,216,030.38) | (11,782,312.04) |
| Upside | -4052367958.3% - -3867596781.3% | -4062866320.6% |
| Date | P/E |
| 2025-07-02 | 0.00 |
| 2025-06-30 | 0.00 |
| 2025-06-24 | 0.00 |
| 2025-06-23 | 0.00 |
| 2025-06-20 | 0.00 |
| 2025-06-18 | 0.00 |
| 2025-06-16 | 0.00 |
| 2025-06-13 | 0.00 |
| 2025-06-12 | 0.00 |
| 2025-06-05 | 0.00 |
| 2025-05-30 | 0.00 |
| 2025-05-20 | 0.00 |
| 2025-05-19 | 0.00 |
| 2025-05-14 | 0.00 |
| 2025-05-13 | 0.00 |
| 2025-05-07 | 0.00 |
| 2025-05-01 | -0.00 |
| 2025-04-30 | 0.00 |
| 2025-04-28 | -0.00 |
| 2025-04-21 | -0.00 |
| 2025-04-17 | 0.00 |
| 2025-04-15 | 0.00 |
| 2025-04-14 | 0.00 |